NCT06111053

Brief Summary

The purpose of this study is to provide preliminary information on the effect of electronic nicotine delivery systems (ENDS) provisions and contingent incentives (CI) on smoking in individuals with overweight/obesity who smoke cigarettes (SWO). All participants will be provided information on the comparative risk of ENDS relative to cigarette smoking, and a randomized group of participants will be provided ENDS provisions for 6 weeks. All participants will complete breath samples for 28 days to measure their exhaled carbon monoxide and will either receive fixed incentives for sample completion or receive varying incentives contingent on their carbon monoxide levels. Researchers will compare groups to understand the effect of each condition on smoking-related behavior.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 20, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 1, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2024

Completed
Last Updated

November 18, 2024

Status Verified

November 1, 2024

Enrollment Period

10 months

First QC Date

October 20, 2023

Last Update Submit

November 15, 2024

Conditions

Keywords

obesityoverweightelectronic nicotine delivery systemscontingent incentivesharm reduction

Outcome Measures

Primary Outcomes (2)

  • Use of Cigarettes and ENDS

    Daily use of cigarettes and ENDS will be determined using the Timeline Follow-Back (TLFB) in follow-up assessments post-treatment.

    Assessed 4, 6, and 12 weeks follow-up

  • Within-Treatment Smoking Abstinence

    Number of days during the incentive period with CO verified abstinence from smoking

    Daily for 4 weeks

Secondary Outcomes (5)

  • Motivation to change

    Assessed 4, 6, and 12 weeks follow-up

  • Carbon monoxide (CO)

    Assessed 4, 6, and 12 weeks follow-up

  • Cigarette and E-Cigarette Dependence

    Assessed 4, 6, and 12 weeks follow-up

  • Comparing E-Cigarettes and Cigarettes Questionnaire

    Assessed 4, 6, and 12 weeks follow-up

  • Weight

    Assessed 4, 6, and 12 weeks follow-up

Study Arms (4)

ENDS and CI

EXPERIMENTAL

Participants in this arm will receive information about the comparative risk of electronic nicotine delivery systems (ENDS) relative to smoking as well as 6 weeks' worth of provisions of ENDS and will receive 4 weeks of monetary incentives for complete abstinence from smoking (after a controlled ramp down of smoking).

Other: ENDSOther: CI

No ENDS and CI

EXPERIMENTAL

Participants in this arm will receive information about the comparative risk of electronic nicotine delivery systems (ENDS) relative to smoking and will receive 4 weeks of monetary incentives for complete abstinence from smoking (after a controlled ramp down of smoking).

Other: CIOther: No ENDS

ENDS and NI

EXPERIMENTAL

Participants in this arm will receive information about the comparative risk of electronic nicotine delivery systems (ENDS) relative to smoking as well as 6 weeks' worth of provisions of ENDS and will receive monetary incentives for providing breath samples only (non-contingent on smoking status).

Other: ENDSOther: NI

No ENDS and NI

EXPERIMENTAL

Participants in this arm will receive information about the comparative risk of electronic nicotine devices (ENDs) relative to smoking and will receive monetary incentives for providing breath samples only (non-contingent on smoking status).

Other: No ENDSOther: NI

Interventions

ENDSOTHER

Participants in active comparator groups that include ENDS will receive 6-weeks worth of ENDS supplies.

Also known as: Electronic Nicotine Delivery Systems
ENDS and CIENDS and NI
CIOTHER

Participants in active comparator groups will receive incentives that vary based on participant abstinence from smoking, measured by a carbon monoxide breath sample.

Also known as: Contingent Incentives
ENDS and CINo ENDS and CI
No ENDSOTHER

Participants in active comparator groups labeled No ENDS will only receive information about the comparative risk of ENDS relative to combustible cigarettes.

No ENDS and CINo ENDS and NI
NIOTHER

Participants in active comparator groups labeled NI will receive compensation for each breath sample provided throughout the study, with no variation.

Also known as: Non-Contingent Incentives
ENDS and NINo ENDS and NI

Eligibility Criteria

Age21 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI ≥ 25 kg/m2
  • smoked ≥ 5 cigarettes/day during the past year
  • or older
  • exhaled CO of \> 6 ppm at Baseline
  • willing to use ENDs for 6 weeks
  • daily access to a Bluetooth-enabled smartphone/tablet

You may not qualify if:

  • planning to set a smoking quit date in the next 30 days
  • receiving smoking cessation treatment of any kind in the past 30 days
  • currently using ENDS \> 4 day per month
  • hospitalized for mental illness in past 30 days
  • heart-related event (e.g., heart attack, severe angina) in past 30 days
  • resides with another person enrolled in the study
  • pregnant, nursing, or planning to become pregnant in the next 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brown University School of Public Health

Providence, Rhode Island, 02912, United States

Location

MeSH Terms

Conditions

ObesitySmoking CessationOverweightVapingHarm Reduction

Interventions

Electronic Nicotine Delivery Systems

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsHealth BehaviorBehaviorSmoking

Intervention Hierarchy (Ancestors)

Smoking DevicesManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Cara M Murphy, Ph.D.

    Brown University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessor will not know the outcome of randomized assignment.
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: A 2x2 factorial design comparing * contingent incentives (CI) for smoking abstinence to noncontingent incentives (NI) * the provision of ENDS (ENDS) to no provision of ENDS (No ENDS) SWO (N=36) will be randomized to receive 4 weeks of monetary incentives contingent on their smoking abstinence (CI) or after completing breath samples only (NI). They will also be randomized to receive either a 6-week provision of ENDS with information communicating the comparative risk of ENDS use relative to smoking or information communicating the comparative risk of ENDS relative to smoking without ENDS provision. Conditions are as follows: * C1: ENDS + CI * C2: NoENDS + CI * C3: ENDS + NI * C4: NoENDS + NI
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 20, 2023

First Posted

November 1, 2023

Study Start

November 1, 2023

Primary Completion

August 28, 2024

Study Completion

August 28, 2024

Last Updated

November 18, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share

Deidentified data will be kept and used for future research on chronic disease and substance use.

Time Frame
Clinical Laboratory Core data collected to fulfill the aims of the Center for Addiction and Disease Risk Exacerbation will be available to request immediately following publication with no prespecified end date.
Access Criteria
After all data are collected and the results of the study are published, deidentified data and biospecimens may be made available to other qualified investigators at Brown or other institutions upon request. The request will be evaluated by the investigators to ensure that it meets reasonable demands of scientific integrity.

Locations